{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:00:34Z","timestamp":1781704834814,"version":"3.54.5"},"reference-count":9,"publisher":"Norwegian Medical Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.19.0558","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T08:15:11Z","timestamp":1580976911000},"source":"Crossref","is-referenced-by-count":2,"title":["Alvorlig delir etter GHB-misbruk"],"prefix":"10.4045","volume":"140","author":[{"given":"Einar Vie","family":"Sundal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse Melv\u00e6r","family":"Giil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Mirrakhimov\u00a0AE, Voore\u00a0P, Halytskyy\u00a0O et al. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract 2015; 2015: 260385. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25954513&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1155%2F2015%2F260385","DOI":"10.1155\/2015\/260385"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Kamal\u00a0RM, van Noorden\u00a0MS, Wannet\u00a0W et al. Pharmacological treatment in \u03b3-hydroxybutyrate (GHB) and \u03b3-butyrolactone (GBL) dependence: detoxification and relapse prevention. CNS Drugs 2017; 31: 51\u201364. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28004314&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs40263-016-0402-z","DOI":"10.1007\/s40263-016-0402-z"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Lingford-Hughes\u00a0AR, Welch\u00a0S, Peters\u00a0L et al. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 2012; 26: 899\u2013952. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22628390&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F0269881112444324","DOI":"10.1177\/0269881112444324"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Snead\u00a0OC, Gibson\u00a0KM. \u03b3-hydroxybutyric acid. N Engl J Med 2005; 352: 2721\u201332. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15987921&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMra044047","DOI":"10.1056\/NEJMra044047"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Sigel\u00a0E, Steinmann\u00a0ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem 2012; 287: 40224\u201331. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23038269&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1074%2Fjbc.R112.386664","DOI":"10.1074\/jbc.R112.386664"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Garcia\u00a0PS, Kolesky\u00a0SE, Jenkins\u00a0A. General anesthetic actions on GABA(A) receptors. Curr Neuropharmacol 2010; 8: 2\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20808541&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2174%2F157015910790909502","DOI":"10.2174\/157015910790909502"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Scott-Warren\u00a0V, Sebastian\u00a0J. Dexmedetomidine: its use in intensive care medicine and anaesthesia. BJA Educ 2015; 16: 242\u20136. Crossref: http:\/\/dx.doi.org\/10.1093%2Fbjaed%2Fmkv047","DOI":"10.1093\/bjaed\/mkv047"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Tay\u00a0EM, Graham\u00a0RI, Day\u00a0RO. Severe GHB withdrawal delirium managed with dexmedetomidine. Med J Aust 2016; 205: 251\u20132. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27627929&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.5694%2Fmja16.00269","DOI":"10.5694\/mja16.00269"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Beurmanjer\u00a0H, Kamal\u00a0RM, de Jong\u00a0CAJ et al. Baclofen to prevent relapse in gamma-hydroxybutyrate (GHB)-dependent patients: A multicentre, open-label, non-randomized, controlled trial. CNS Drugs 2018; 32: 437\u201342. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29651711&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs40263-018-0516-6","DOI":"10.1007\/s40263-018-0516-6"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:41:17Z","timestamp":1781703677000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/01\/kort-kasuistikk\/alvorlig-delir-etter-ghb-misbruk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":9,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,4]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.19.0558","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]}}}